Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Central Nervous System Neoplasms 38Head and Neck Neoplasms 32Lung Neoplasms 31Squamous Cell Carcinoma of Head and Neck 28Lymphoma 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Breast Neoplasms 18Brain Neoplasms 18Leukemia 15Glioblastoma 15Sarcoma 13Gliosarcoma 13Uterine Cervical Neoplasms 12Astrocytoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Adenocarcinoma of Lung 11Burkitt Lymphoma 10Rhabdomyosarcoma 9Neoplasm Metastasis 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Rectal Neoplasms 8Radiation Injuries 8Oligodendroglioma 8Esophageal Neoplasms 8Colorectal Neoplasms 8Adenocarcinoma Of Esophagus 8Urinary Bladder Neoplasms 6Stomach Neoplasms 6

Interventions

Polymerase Chain Reaction 5Watchful Waiting 2Taxes 2Paclitaxel 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Etoposide 2Cyclophosphamide 2Cisplatin 2Carboplatin 2Biopsy 2nirogacestat 1fludarabine 1emvododstat 1carmustine, poliferprosan 20 drug combination 1axicabtagene ciloleucel 1Vorinostat 1Vincristine 1Vinblastine 1Sodium Chloride 1Smoking Devices 1Restraint, Physical 1Remote Patient Monitoring 1Radiotherapy 1Radiation 1Procarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × HIV Infections × Radiotherapy × Clear all
NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

AIDS Malignancy Consortium

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡